Cesar Roman Email

Chief Staff, Clinical Operations LatAm . bioMerieux

Current Roles

Employees:
13886
Revenue:
$2.2B
About
Pioneering Diagnostics\n\nA world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. \n\nIn 2019, revenues reached €2.7 billion, with over 90% of international sales. \nbioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. \n\nIts products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. \n\nbioMérieux is listed on the Euronext Paris stock market.\n\nSymbol: BIM – ISIN Code: FR0013280286\nReuters: BIOX.PA/Bloomberg: BIM.FP
bioMerieux Address
100 Rodolphe Street
Durham, NC
United States
bioMerieux Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.